Singapore: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Singapore

The Singaporean market for other medicaments for therapeutic or prophylactic uses shrank notably to $X in 2022, declining by X% against the previous year. In general, consumption, however, continues to indicate a perceptible decline. Over the period under review, the market hit record highs at $X in 2018; however, from 2019 to 2022, consumption stood at a somewhat lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Singapore

In value terms, production of other medicaments for therapeutic or prophylactic uses rose notably to $X in 2022 estimated in export price. In general, production saw a strong expansion. The pace of growth appeared the most rapid in 2015 with an increase of X%. Over the period under review, production of reached the maximum level at $X in 2018; however, from 2019 to 2022, production stood at a somewhat lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Singapore

In 2022, the amount of other medicaments for therapeutic or prophylactic uses exported from Singapore skyrocketed to X tons, rising by X% on 2021. Overall, exports posted a significant expansion. The growth pace was the most rapid in 2021 with an increase of X%. Over the period under review, the exports of reached the maximum in 2022 and are expected to retain growth in the immediate term.

In value terms, exports of other medicaments for therapeutic or prophylactic uses fell to $X in 2022. In general, exports continue to indicate a strong increase. The pace of growth was the most pronounced in 2018 with an increase of X%. The exports peaked at $X in 2021, and then declined in the following year.

Exports by Country

Japan (X tons), Argentina (X tons) and the United States (X tons) were the main destinations of exports of other medicaments for therapeutic or prophylactic uses from Singapore, with a combined X% share of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Japan (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, the United States ($X) remains the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Singapore, comprising X% of total exports. The second position in the ranking was held by the UK ($X), with a X% share of total exports. It was followed by Japan, with an X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to the United States totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the UK (X% per year) and Japan (X% per year).

Export Prices by Country

In 2022, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, shrinking by X% against the previous year. Over the period under review, the export price recorded a abrupt setback. The growth pace was the most rapid in 2018 when the average export price increased by X%. Over the period under review, the average export prices hit record highs at $X per ton in 2020; however, from 2021 to 2022, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was the UK ($X per ton), while the average price for exports to Argentina ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Luxembourg (X%), while the prices for the other major destinations experienced a decline.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Singapore

After three years of decline, purchases abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X tons in 2022. Overall, imports, however, continue to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2014 when imports increased by X%. As a result, imports attained the peak of X tons. From 2015 to 2022, the growth of imports of remained at a lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses soared to $X in 2022. Over the period under review, imports showed temperate growth. The most prominent rate of growth was recorded in 2014 when imports increased by X%. As a result, imports attained the peak of $X. From 2015 to 2022, the growth of imports of failed to regain momentum.

Imports by Country

Japan (X tons), India (X tons) and Germany (X tons) were the main suppliers of imports of other medicaments for therapeutic or prophylactic uses to Singapore, with a combined X% share of total imports.

From 2012 to 2022, the biggest increases were recorded for Germany (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Germany ($X), Japan ($X) and Ireland ($X) appeared to be the largest other medicaments for therapeutic or prophylactic uses suppliers to Singapore, with a combined X% share of total imports.

Ireland, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, growing by X% against the previous year. Overall, import price indicated a strong expansion from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, import price for other medicaments for therapeutic or prophylactic uses increased by X% against 2014 indices. As a result, import price attained the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Germany ($X per ton), while the price for India ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United States (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :